Sumitomo Mitsui DS Asset Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.46M | Hold |
51,315
| – | – | 0.02% | 433 |
|
|
2026
Q1 | $3.22M | Buy |
51,315
+1,081
| +2% | +$75.3K | 0.03% | 420 |
|
|
2025
Q4 | $3.33M | Buy |
50,234
+1,153
| +2% | +$74.5K | 0.03% | 408 |
|
|
2025
Q3 | $3.3M | Sell |
49,081
-86
| -0.2% | -$6.81K | 0.03% | 395 |
|
|
2025
Q2 | $4.29M | Buy |
49,167
+1,183
| +2% | +$92.7K | 0.04% | 332 |
|
|
2025
Q1 | $3.28M | Buy |
47,984
+721
| +2% | +$58.8K | 0.03% | 383 |
|
|
2024
Q4 | $3.68M | Buy |
47,263
+6,290
| +15% | +$466K | 0.04% | 346 |
|
|
2024
Q3 | $2.75M | Buy |
40,973
+527
| +1% | +$43.3K | 0.03% | 406 |
|
|
2024
Q2 | $4.59M | Buy |
40,446
+3,899
| +11% | +$493K | 0.05% | 266 |
|
|
2024
Q1 | $5.07M | Buy |
36,547
+251
| +0.7% | +$31.6K | 0.06% | 242 |
|
|
2023
Q4 | $4.5M | Buy |
36,296
+295
| +0.8% | +$30.1K | 0.06% | 279 |
|
|
2023
Q3 | $3.36M | Buy |
36,001
+2,874
| +9% | +$324K | 0.05% | 291 |
|
|
2023
Q2 | $4.26M | Buy |
33,127
+280
| +0.9% | +$33.9K | 0.07% | 239 |
|
|
2023
Q1 | $3.82M | Buy |
32,847
+3,222
| +11% | +$361K | 0.07% | 235 |
|
|
2022
Q4 | $3.35M | Buy |
29,625
+1,768
| +6% | +$194K | 0.07% | 241 |
|
|
2022
Q3 | $2.24M | Buy |
27,857
+2,001
| +8% | +$169K | 0.05% | 307 |
|
|
2022
Q2 | $1.93M | Buy |
25,856
+136
| +0.5% | +$12.4K | 0.05% | 322 |
|
|
2022
Q1 | $3.29M | Buy |
25,720
+72
| +0.3% | +$7.88K | 0.07% | 237 |
|
|
2021
Q4 | $3.44M | Buy |
25,648
+1,532
| +6% | +$220K | 0.07% | 232 |
|
|
2021
Q3 | $3.3M | Buy |
24,116
+924
| +4% | +$117K | 0.08% | 223 |
|
|
2021
Q2 | $2.48M | Sell |
23,192
-116
| -0.5% | -$11.1K | 0.06% | 284 |
|
|
2021
Q1 | $2.09M | Buy |
23,308
+88
| +0.4% | +$8.26K | 0.05% | 300 |
|
|
2020
Q4 | $2.15M | Buy |
23,220
+68
| +0.3% | +$6.07K | 0.06% | 279 |
|
|
2020
Q3 | $2.38M | Buy |
23,152
+364
| +2% | +$38K | 0.08% | 211 |
|
|
2020
Q2 | $2.31M | Buy |
22,788
+2,888
| +15% | +$258K | 0.08% | 203 |
|
|
2020
Q1 | $1.34M | Buy |
19,900
+156
| +0.8% | +$9.71K | 0.06% | 277 |
|
|
2019
Q4 | $1.08M | Buy |
19,744
+4
| +0% | +$190 | 0.04% | 399 |
|
|
2019
Q3 | $736K | Buy |
19,740
+3,444
| +21% | +$134K | 0.03% | 474 |
|
|
2019
Q2 | $610K | Sell |
16,296
-42,892
| -72% | -$1.35M | 0.02% | 502 |
|
|
2019
Q1 | $1.76M | Sell |
59,188
-27,136
| -31% | -$954K | 0.03% | 378 |
|
|
2018
Q4 | $2.58M | Buy |
86,324
+12,488
| +17% | +$396K | 0.05% | 267 |
|
|
2018
Q3 | $2.64M | Sell |
73,836
-81,464
| -52% | -$2.53M | 0.04% | 311 |
|
|
2018
Q2 | $3.69M | Sell |
155,300
-5,332
| -3% | -$113K | 0.06% | 249 |
|
|
2018
Q1 | $2.98M | Buy |
+160,632
| New | +$2.38M | 0.04% | 294 |
|
|
2017
Q4 | – | Sell |
-24,348
| Closed | -$297K | – | 787 |
|
|
2017
Q3 | $297K | Sell |
24,348
-2,536
| -9% | -$44.8K | ﹤0.01% | 726 |
|
|
2017
Q2 | $491K | Sell |
26,884
-188
| -0.7% | -$3.47K | 0.01% | 676 |
|
|
2017
Q1 | $573K | Buy |
27,072
+3,472
| +15% | +$67.8K | 0.01% | 642 |
|
|
2016
Q4 | $352K | Buy |
+23,600
| New | +$418K | 0.01% | 697 |
|
Other funds holding DXCM
FFM
PCM
FMI
OIAM
GI
ETC
Sumitomo Mitsui DS Asset Management's DXCM Position: Q2 2026 in Review
Sumitomo Mitsui DS Asset Management held its DexCom (DXCM) position steady in Q2 2026 at 51,315 shares worth $3.46M. The position accounts for 0.02% of the portfolio, ranked #433.
Sumitomo Mitsui DS Asset Management first reported a position in DXCM in Q4 2016 and has held it in 38 quarters since. The position peaked at $5.07M in Q1 2024. 224 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Sumitomo Mitsui DS Asset Management held 51,315 shares of DexCom worth $3.46M as of Q2 2026.
- Sumitomo Mitsui DS Asset Management left its DexCom share count unchanged in Q2 2026.
- DexCom made up 0.02% of Sumitomo Mitsui DS Asset Management's portfolio in Q2 2026, its #433 holding.
- Sumitomo Mitsui DS Asset Management first reported a position in DexCom in Q4 2016 and has held it in 38 quarters since.
- Sumitomo Mitsui DS Asset Management's DexCom position peaked at $5.07M in Q1 2024.
- 224 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Sumitomo Mitsui DS Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.